4.6 Article

Long term health care consumption and cost expenditure in systolic heart failure

Journal

EUROPEAN JOURNAL OF INTERNAL MEDICINE
Volume 24, Issue 3, Pages 260-265

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejim.2012.11.015

Keywords

Heart failure; Health care cost; Quality of life; Chronic disease

Funding

  1. Stockholm County Council
  2. Karolinska Institutet

Ask authors/readers for more resources

Background: The prevalence, health care consumption, and mortality increase in elderly patients with heart failure. This study aimed to analyse long term cost expenditure and predictors of health care consumption in these patients. Methods: We included 208 patients aged 60 years or older and hospitalised with heart failure (NYHA class II-IV and left ventricular systolic dysfunction); 58% were men, mean age 76 years, and mean ejection fraction 0.34. Data on all hospital admissions, discharge diagnoses, lengths of stay, and outpatient visits were collected from the National Board of Health and Welfare. We obtained data of all health care consumption for each individual. Results: After 8-12 years of prospective follow up 72% were dead (median survival 4.6 years). Main drivers of health care expenditure were non-cardiac (40%) and cardiac (29%) hospitalizations, and visits to primary care centres (16%), and hospital outpatient clinics (15%). On average, health care expenditures were (sic) 36,447 per patient during follow up. The average yearly cost per patient was about 5,700(sic), in contrast to the estimated consumption of primary and hospital care in the general population: (sic) 1,956 in 65-74 year olds and (sic) 2,701 in 75-84 year olds. Poor quality of life (Nottingham Health Profile) was the strongest independent predictor of total health care consumption and costs (p<0.001; by multivariate analyses). Conclusion: Health care costs in chronic systolic heart failure are at least two-fold higher than in the general population. Quality of life is a strong independent predictor of health care consumption. (C) 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available